logo
Alpine still working on large electric SUVs despite shelving US return

Alpine still working on large electric SUVs despite shelving US return

7NEWS3 days ago
Although Alpine isn't returning to the US as initially envisaged, the company is still working on two larger electric SUVs, and an electric sedan.
One SUV is thought to be a model designed to take on the Porsche Cayenne, while the other SUV would be the next step up in size. The sedan is expected to be a sedan around five metres in length.
Antony Villain, Alpine's chief designer, told Autocar at the Goodwood Festival of Speed 'we are working on [the large vehicle family] today'.
CarExpert can save you thousands on a new car. Click here to get a great deal.
Mr Villain said it was necessary to have 'something in the D- or E-segment' if the company is to 'expand more globally'.
Alpine's current European lineup consists of the A110 (bottom) mid-engine coupe, the A290 (above) — a hot version of the all-electric Renault 5 — and the A390 (below), a sporty electric 'coupe' SUV.
Right now the A390 is the brand's largest car, and sits in the European C-segment. It measures 4615mm long, making it a little smaller than the first-generation Porsche Macan.
As part of the Renaultion plan, Alpine was aiming to sell 150,000 globally by 2030. A key component in reaching that figure was launching in the US by 2027.
In April this year, Renault indefinitely delayed Alpine's US launch due to the uncertainty around the tariff situation in the US.
As it stands, the tariff on cars imported to the US from the EU will rise to 30 per cent from August 1. The EU and US are currently negotiating an agreement that sources indicate will be similar to the one agreed to with Japan, where automotive imports are taxed at 15 per cent.
According to Mr Villain 'there are some other countries where they look for bigger cars'. Although the design chief wouldn't name names, the only other market where larger vehicles might sell in significant numbers is China.
It's not clear how Alpine could crack the Chinese market without producing vehicles there, as fully imported vehicles incur heavy tariffs.
Renault, Alpine's parent, currently doesn't sell any cars in China, but it does have a series of partnerships with Geely. The two operate a joint venture company to house their internal combustion engine development and production facilities, and Renault has access to some of Geely's platforms.
Under the plan announced in 2021, Renault would produce localised — namely restyled and rebadged — versions of Geely vehicles in South Korea.
Geely would in turn produce a clutch of Renault-ised Geely Group products in China. So far, the only fruit of this agreement is the made-in-South Korea Grand Koleos, which is essentially a lightly redesigned Geely Monjaro/Xingyue L.
If Alpine does end up developing and producing vehicles larger than the A390, it's unclear if they will come to Australia. The brand has says it will return to Australia with the A390, but other products have yet to be confirmed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ASX set to slip, Wall Street hits record; US-EU reach trade deal
ASX set to slip, Wall Street hits record; US-EU reach trade deal

Sydney Morning Herald

time21 minutes ago

  • Sydney Morning Herald

ASX set to slip, Wall Street hits record; US-EU reach trade deal

Wall Street ended the week on a positive note, with stocks hitting fresh all-time highs, while on Sunday, the United States struck a framework trade deal with the European Union, averting a spiralling battle between two allies which account for almost a third of global trade. The trade deal announcement came after European Commission President Ursula von der Leyen travelled for talks with US President Donald Trump at his golf course in western Scotland to push a hard-fought deal over the line, which will see a 15 per cent US import tariff imposed on most EU goods. 'I think this is the biggest deal ever made,' Trump told reporters after an hour-long meeting with von der Leyen, who said the 15 per cent tariff applied 'across the board'. 'We have a trade deal between the two largest economies in the world, and it's a big deal. It's a huge deal. It will bring stability. It will bring predictability,' she said. The deal, that also includes $US600 billion ($914 billion) of EU investments in the United States and significant EU purchases of US energy and military equipment, will indeed bring clarity for EU companies. However, the baseline tariff of 15 per cent will be seen by many in Europe as a poor outcome compared to the initial European ambition of a zero-for-zero tariff deal, although it is better than the threatened 30 per cent rate. The deal mirrors parts of the framework agreement the United States clinched with Japan last week. On Friday, the S&P 500 rose 0.4 per cent to set an all-time high, the fifth time it did so this week. The Dow Jones climbed 208 points, or 0.5 per cent, and the Nasdaq composite added 0.2 per cent to its own record set the day before. A closely watched gauge of equity volatility – the VIX – closed below 15. The Australian sharemarket is set to slip, with futures, set before the US-EU trade deal was announced, pointing to a slide of 5 points, or 0.1 per cent, at the open.

ASX set to slip, Wall Street hits record; US-EU reach trade deal
ASX set to slip, Wall Street hits record; US-EU reach trade deal

The Age

time21 minutes ago

  • The Age

ASX set to slip, Wall Street hits record; US-EU reach trade deal

Wall Street ended the week on a positive note, with stocks hitting fresh all-time highs, while on Sunday, the United States struck a framework trade deal with the European Union, averting a spiralling battle between two allies which account for almost a third of global trade. The trade deal announcement came after European Commission President Ursula von der Leyen travelled for talks with US President Donald Trump at his golf course in western Scotland to push a hard-fought deal over the line, which will see a 15 per cent US import tariff imposed on most EU goods. 'I think this is the biggest deal ever made,' Trump told reporters after an hour-long meeting with von der Leyen, who said the 15 per cent tariff applied 'across the board'. 'We have a trade deal between the two largest economies in the world, and it's a big deal. It's a huge deal. It will bring stability. It will bring predictability,' she said. The deal, that also includes $US600 billion ($914 billion) of EU investments in the United States and significant EU purchases of US energy and military equipment, will indeed bring clarity for EU companies. However, the baseline tariff of 15 per cent will be seen by many in Europe as a poor outcome compared to the initial European ambition of a zero-for-zero tariff deal, although it is better than the threatened 30 per cent rate. The deal mirrors parts of the framework agreement the United States clinched with Japan last week. On Friday, the S&P 500 rose 0.4 per cent to set an all-time high, the fifth time it did so this week. The Dow Jones climbed 208 points, or 0.5 per cent, and the Nasdaq composite added 0.2 per cent to its own record set the day before. A closely watched gauge of equity volatility – the VIX – closed below 15. The Australian sharemarket is set to slip, with futures, set before the US-EU trade deal was announced, pointing to a slide of 5 points, or 0.1 per cent, at the open.

Drug giants targeting Australia's PBS are paying tiny amounts of tax
Drug giants targeting Australia's PBS are paying tiny amounts of tax

AU Financial Review

time21 minutes ago

  • AU Financial Review

Drug giants targeting Australia's PBS are paying tiny amounts of tax

Global pharmaceutical giants, including Pfizer and Johnson & Johnson, are paying a tiny fraction of the billions of dollars they earn from drug sales in local taxes, at a time when they're lobbying US President Donald Trump to force an overhaul of Australia's Pharmaceutical Benefits Scheme. An analysis of earnings statements filed with the corporate regulator by five of the biggest US and European drugmakers shows the companies on average pay between 2 per cent and 4 per cent of their Australian sales in income tax.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store